Albanna Amro A. 4
4 · ADiTx Therapeutics, Inc. · Filed Jul 31, 2020
Insider Transaction Report
Form 4
Albanna Amro A.
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Exercise of In-Money
Series B Warrant
2020-07-24$11.25/sh−35,555$399,994→ 0 total(indirect: See Footnote)Exercise: $0.00From: 2020-07-02Exp: 2025-06-29→ Common Stock (35,555 underlying) - Exercise of In-Money
Series B Warrant
2020-07-24$11.25/sh−38,055$428,119→ 0 totalExercise: $0.00From: 2020-07-02Exp: 2025-06-29→ Common Stock (38,055 underlying) - Exercise of In-Money
Common Stock
2020-07-24$11.25/sh+38,055$428,119→ 476,110 total - Exercise of In-Money
Common Stock
2020-07-24$11.25/sh+35,555$399,994→ 71,110 total(indirect: See Footnote)
Footnotes (1)
- [F1]Held beneficially by the wife of the Reporting Person.